Home > Insider Trading > Filing (0001415889-22-012355)

Filing Details

Accession Number:: 0001415889-22-012355
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-12-09 18:00:25
Reporting Period:: 2022-12-07

Accepted Time:: 2022-12-09 18:00:25
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1798749	Aerovate Therapeutics Inc.	AVTE	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1413006	A George Eldridge	C/O Aerovate Therapeutics, Inc. 930 Winter Street, Suite M-500 Waltham MA 02451	See Remarks	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-12-07	11,637	$2.14	13,597	No	4	M	Direct
Common Stock	Disposition	2022-12-07	7,079	$19.37	6,518	No	4	S	Direct
Common Stock	Disposition	2022-12-07	4,558	$20.40	1,960	No	4	S	Direct
Common Stock	Acquisiton	2022-12-08	12,011	$2.14	13,971	No	4	M	Direct
Common Stock	Disposition	2022-12-08	960	$20.12	13,011	No	4	S	Direct
Common Stock	Disposition	2022-12-08	20	$20.58	12,991	No	4	S	Direct
Common Stock	Disposition	2022-12-08	11,031	$24.20	1,960	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2022-12-07	11,637	$0.00	11,637	$2.14
Common Stock	Stock Option (Right to Buy)	Disposition	2022-12-08	1,887	$0.00	1,887	$2.14
Common Stock	Stock Option (Right to Buy)	Disposition	2022-12-08	10,124	$0.00	10,124	$2.14

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
84,656	2031-04-01	No	4	M	Direct
82,769	2031-04-01	No	4	M	Direct
40,726	2031-04-01	No	4	M	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.00 to $19.97, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.02 to $20.56, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.575 to $20.54, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.50, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
A total of 98,676 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter.
A total of 50,850 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on March 22, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter.